|
|
|
National Stock Number:
6505-01-155-5157
Federal Supply Class:
6505
National Item Identification Number:
011555157
Description:
NAPROXEN SODIUM TABLETS
|
Manufacturer Information:
| 00591-0792-01 | 1UVZ2 | WATSON PHARMACEUTICALS INC. | | ANAPROX | 26282 | SYNTEX LABORATORIES INC | | ANAPROX TABLETS | 26282 | SYNTEX LABORATORIES INC | | NDC00093-0536-01 | 3V8D7 | TEVA PHARMACEUTICALS USA, INC. | | NDC00004-6202-01 | 66002 | ROCHE LABORATORIES INC. | | NDC00093-0536-01 | 80608 | LEMMON CO | | NDC52544-0792-01 | 0BN85 | WATSON LABS INC | | NDC18393-0274-42 | 26282 | SYNTEX LABORATORIES INC | | NDC00143-9916-01 | 32655 | HIKMA PHARMACEUTICALS USA INC. | | NDC42291-0531-01 | 4QGW8 | AVKARE LLC | | NDC00781-1187-01 | 59043 | GENEVA PHARMACEUTICALS INC | | NDC00378-0537-01 | 60895 | MYLAN PHARMACEUTICALS INC | | NDC00591-0792-01 | 62051 | DANBURY PHARMACAL INC | | NDC50228-0432-01 | 8NLP1 | SCIEGEN PHARMACEUTICALS INC |
|
Techincal Specification:
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 275.000 MILLIGRAMS NAPROXEN SODIUM ACTIVE INGREDIENT | | PART NAME ASSIGNED BY CONTROLLING AGENCY | NAPROXEN SODIUM TABLETS USP 275MG 100S BT | | MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA | | PRIMARY CONTAINER CONTENT QUANTITY | 100.000 TABLETS | | PRIMARY CONTAINER TYPE | BOTTLE |
|